Received Aug 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 3T5L9 | — |
Expire dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 6-year-old male patient who received HBV (Engerix B) (batch number 3T5L9, expiry date 09-MAR-2025) for prophylaxis. On 01-AUG-2025, the patient received the 1st dose of Engerix B. On 01-AUG-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Expire dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-AUG-2025 The reporter stated that they had a patient, who got a vaccine, it was the Hep B vaccine (Engerix-B), and it was expired by a couple of months, which led to expired vaccine used.